Literature DB >> 33923569

Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency.

Mònica Pons1, Alexa Núñez2,3, Cristina Esquinas2,3, María Torres-Durán4, Juan Luis Rodríguez-Hermosa5, Myriam Calle5, Ramón Tubio-Pérez4, Irene Belmonte2, Francisco Rodríguez-Frías6,7, Esther Rodríguez2, Joan Genescà1,7, Marc Miravitlles2,3,8, Miriam Barrecheguren2.   

Abstract

Screening of liver disease in alpha-1 antitrypsin deficiency (AATD) is usually carried out with liver enzymes, with low sensitivity. We conducted a multicenter cross-sectional study aiming to describe the utility of transient elastography for the identification of liver disease in patients with AATD. A total of 148 AATD patients were included. Among these, 54.7% were Pi*ZZ and 45.3% were heterozygous for the Z allele. Between 4.9% and 16.5% of patients had abnormal liver enzymes, without differences among genotypes. Liver stiffness measurement (LSM) was significantly higher in Pi*ZZ individuals than in heterozygous Z (5.6 vs. 4.6 kPa; p = 0.001). In total, in 8 (5%) individuals LSM was >7.5 kPa, considered significant liver fibrosis, and ≥10 kPa in 3 (1.9%) all being Pi*ZZ. Elevated liver enzymes were more frequently observed in patients with LSM > 7.5 kPa, but in 5 out of 8 of these patients all liver enzymes were within normal range. In patients with AATD, the presence of abnormal liver enzymes is frequent; however, most of these patients do not present significant liver fibrosis. Transient elastography can help to identify patients with liver fibrosis even with normal liver enzymes and should be performed in all Z-allele carriers to screen for liver disease.

Entities:  

Keywords:  alpha1-antitrypsin deficiency; liver disease; transient elastography

Year:  2021        PMID: 33923569     DOI: 10.3390/jcm10081724

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

Review 1.  Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide.

Authors:  Cristina Martinez-González; Ignacio Blanco; Isidro Diego; Patricia Bueno; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-17

2.  Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease.

Authors:  Lorenz Balcar; Bernhard Scheiner; Markus Urheu; Patrick Weinberger; Rafael Paternostro; Benedikt Simbrunner; Lukas Hartl; Mathias Jachs; David Bauer; Georg Semmler; Claudia Willheim; Matthias Pinter; Peter Ferenci; Michael Trauner; Thomas Reiberger; Albert Friedrich Stättermayer; Mattias Mandorfer
Journal:  JHEP Rep       Date:  2022-08-20

3.  Special Issue: Rare Respiratory Diseases: A Personal and Public Health Issue.

Authors:  María Magallón; Lucía Bañuls; Silvia Castillo; María Mercedes Navarro-García; Cruz González; Francisco Dasí
Journal:  J Clin Med       Date:  2021-12-16       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.